March 19, 2021
Vaccine hesitancy and variants challenge efforts to tame COVID-19
The Janssen Biotech, Inc/Johnson & Johnson COVID-19 vaccine received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) on February 27, joining the Pfizer-BioNTech and Moderna vaccines that received EUA in December 2020.
Free Daily News
- Surgical robotics market accelerates as new players challenge industry giants
- Robotic surgery boosts 3-year relapse-free survival in rectal cancer
- Low-cost simulation helps surgical trainees practice crisis skills for major hemorrhage
- Nurse leaders weigh in on NCLEX pass rate decline, impact on workforce readiness
- FDA issues early alerts on multiple high-risk device recalls from J&J, Medtronic, Baxter, Boston Scientific
- New UCSF measure shows 1 in 60 cesarean deliveries involve serious surgical complications
- Hospitals can curb costly post-acute discharges with targeted periop programs, study finds
- Sameness in nursing care puts patients at risk
- CMS’s plan to phase out inpatient-only list could bolster rural ASCs
- AAAHC unveils v44 standards to sharpen focus on patient-centered ambulatory care
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement